India's AstraZeneca Pharma up on import nod for liver cancer drug

Astrazeneca Pharma India

03/03/2025 09:16

** AstraZeneca Pharma ASTR.NS rises 2.7% to 6,872.1 rupees; stock's biggest one-day gain since Feb. 3

** Biopharmaceutical co receives Indian drug regulator's permission to import Durvalumab solution for sale, distribution

** Drug is used to treat patients with a certain type of liver cancer

** Shares mark second-busiest session in about 2 weeks, with more than 11,000 shares traded

** Stock down 8% so far this year, after a 32% gain from 2024

 (Reporting by Aleef Jahan in Bengaluru)

 ((aleefjahan.cs@thomsonreuters.com))